Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on September 26, 2025, that on the previous day, it had repurchased 400,000 of its Ordinary Shares at $1.53 per share. These shares will be held in treasury. Following the transaction, the company's issued Ordinary Share capital is 345,967,440, with 17,793,791 shares held in treasury, leaving 328,173,649 total voting rights. The buyback was authorized at the Annual General Meeting in June 2025, permitting repurchase of up to 14.99% of Ordinary Shares. The company intends to hold repurchased shares in treasury and has not determined a maximum consideration, but will not pay a premium to net asset value.

Disclaimer*

UK 100

Latest directors dealings